Showing results (161-170 of 250) with videos related to
Sort By:
Pageof 25
Medical and Pediatric Oncology|January 1, 1991
Infant leukemia in Japan: clinical and biological analysis of 48 casesE Ishii, J Okamura, M Tsuchida, et al.Cancer Research|March 8, 2000
SN-1, a novel leukemic cell line with t(11;16)(q23;p13): myeloid characteristics and resistance to retinoids and vitamin D3Y Hayashi, Y Honma, N Niitsu, et al.Blood|April 27, 1999
Expression of E2A-HLF chimeric protein induced T-cell apoptosis, B-cell maturation arrest, and development of acute lymphoblastic leukemiaH Honda, T Inaba, T Suzuki, et al.Journal of Immunology (Baltimore, Md. : 1950)|February 15, 1986
Formation of mast cell colonies in methylcellulose by mouse peritoneal cells and differentiation of these cloned cells in both the skin and the gastric mucosa of W/Wv mice: evidence that a common precursor can give rise to both "connective tissue-type" and "mucosal" mast cellsT Kobayashi, T Nakano, T Nakahata, et al.Blood|November 15, 1994
Hereditary hemolytic anemia caused by diverse point mutations of pyruvate kinase gene found in Japan and Hong KongH Kanno, D C Wei, L C Chan, et al.Blood|April 15, 1990
In vivo effects of recombinant human interleukin-6 in primates: stimulated production of plateletsS Asano, A Okano, K Ozawa, et al.Nihon Ketsueki Gakkai Zasshi : Journal of Japan Haematological Society|December 1, 1989
Long-term prognosis and residual abnormalities of idiopathic acquired aplastic anemia in childrenI Tsukimoto, M Tsuchida, A Ohara, et al.British Journal of Haematology|March 1, 1996
Characterization of peripheral blood progenitor cells (PBPC) mobilized by filgrastim (rHuG-CSF) in normal volunteers: dose-effect relationship for filgrastim with the character of mobilized PBPCR Tanaka, T Matsudaira, J Aizawa, et al.The Journal of Experimental Medicine|July 1, 1989
Stimulation of connective tissue-type mast cell proliferation by crosslinking of cell-bound IgEM Takagi, T Nakahata, K Koike, et al.Blood|September 1, 1989
Pathogenic significance of interleukin-6 (IL-6/BSF-2) in Castleman's diseaseK Yoshizaki, T Matsuda, N Nishimoto, et al.Pageof 25